Oral Abstract Session:
213. Late Breaker Oral Abstracts: Influenza and Vaccines
Saturday, October 6, 2018: 10:30 AM-11:45 AM
Room: S 152-154

Tracks: Transplant ID, Pediatric ID, Trainee, Investigative ID, Global ID, HIV-STD-TB, Epidemiology and Infection Control, Adult ID


Moderators:  Timothy Uyeki, MD, MPH, MPP, Centers for Disease Control and Prevention and Natasha B. Halasa, MD, MPH, FPIDS, Vanderbilt University School of Medicine

Presentations:
10:30 AM
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Lee-Jah Chang, MD; Ya Meng, PhD; Helene Janosczyk, MA; Victoria Landolfi, MSc, MBA; H. Keipp Talbot, MD, MPH
10:40 AM
Vaccine Effectiveness of Flucelvax Relative to Inactivated Influenza Vaccine During the 2017-18 Influenza Season in Northern California
Nicola P. Klein, MD, PhD; Bruce Fireman, MA; Kristin Goddard, MPH; Ousseny Zerbo, PhD; Jason Asher, PhD; James Zhou, PhD; James King, MD; Ned Lewis, MPH
10:50 AM
Phase 3 Trial of Baloxavir Marboxil in High Risk Influenza Patients (CAPSTONE-2 Study)
Michael G. Ison, MD MS, FIDSA; Simon Portsmouth, MD; Yuki Yoshida, MS; Takao Shishido, PhD; Frederick Hayden, MD; Takeki Uehara, PhD
11:00 AM
Age-related differences in influenza type/subtype among patients hospitalized with influenza, FluSurv-NET—2017–2018
Shikha Garg, MD, MPH; Alissa O'Halloran, MSPH; Charisse Nitura Cummings, MPH; Evan J. Anderson, MD; Nisha Alden, MPH; Nancy M. Bennett, MD; Laurie Billing, MPH; Shua J. Chai, MD, MPH; Sue Kim, MPH; Ruth Lynfield, MD, FIDSA; Alison Muse, MPH; Andrea Price, LPN; Patricia Ryan, MS; H. Keipp Talbot, MD, MPH; Salina Torres, MPH; Kimberly Yousey-Hindes, MPH, CPH; Ann Thomas, MD, MPH; Carrie Reed, DSc, MPH
11:10 AM
An Enveloped Virus-like Particle (eVLP) Cytomegalovirus (CMV) Vaccine is Immunogenic and Safe: Results of a First-in-Humans Study
Soren Gantt, MD, PhD; Caroline Quach, MD, MSc, FRCPC, FSHEA; David E Anderson, PhD; Francisco Diaz-Mitoma, MD, PhD; Joanne Langley, MD
11:20 AM
Progress Toward a Vaccine for Maternal Immunization to Prevent Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) in Infants
Louis Fries, MD; D Nigel Thomas, PhD; Gale Smith, PhD; Joyce Plested, PhD; Pedro Piedra, MD; Nita Patel, MSc; Iksung Cho, MS; Greg Glenn, MD

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.